Hill-Rom Holdings has been a leading seller of hospital beds in the United states for almost eighty years. But CEO John Greisch wants to branch out. Greisch came to Hill-Rom in 2010 from a high-powered position with Baxter International. In the past seven years, he has burdened Hill-Rom with $2.1 billion in debt with seven major acquisitions, which included Welch Allyn for $2.05 billion and Mortara Instrument for $330 million; but the diversification the deals have brought has paid off. While the hospital bed market is growing at only 1% per year, largely due to industry shifts including more outpatient services and people seeking medical attention outside hospitals, Hill-Rom’s revenue has doubled since 2010 to $2.74 billion, and share price has tripled to $88. Twenty years ago, Hill-Rom earned almost 70% of its income from hospital beds; today, beds account for less than 20% of income. Nationwide, hospital bed counts have fallen, but sales revenues increase as they become increasingly higher-tech.